跳至主要内容
临床试验/NCT06070701
NCT06070701已完成不适用

NOL-Guided Superficial Parasternal Intercostal Plane Block Versus Erector Spinae Plane Block in Open Heart Surgery With Cardiopulmonary Bypass - A Propensity Matched Non-Inferiority Clinical Trial

Institutul de Urgenţă pentru Boli Cardiovasculare Prof.Dr. C.C. Iliescu1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2023年6月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40
试验地点
1
主要终点
Fentanyl consumption (µg/kg)

研究概览

简要总结

This clinical trial focuses on an elaborate, propensity-matched, non-inferiority comparison of NOL-guided Superficial Parasternal Intercostal Plane Block (SPIPB) and Erector Spinae Plane Block (ESPB) within the context of open-heart surgery with cardiopulmonary bypass.

详细描述

A. Ethics

Local Ethics Committee approval and Informed Consent from patient or next-of-kin are obtained prior to study enrollment.

B. Study enrollment

Forty consecutive adult patients scheduled for elective open cardiac surgery under general anesthesia are to receive general anesthesia plus SPIPB. This prospective group of patients will be matched one-to-one to a historical group of 55 patients that underwent open cardiac surgery under general anesthesia combined with ESPB.

C. Methods

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Informed Consent.
  • Elective heart surgery with sternotomy and bypass.
  • Hemodynamic stability prior to induction.
  • Sinus rhythm.

排除标准

  • Known allergy to any of the medications used in the study.
  • Patient refusal to participate in the study.
  • Coagulopathy (INR > 1.5, APTT > 45, Fibrinogen < 150 mg/dl).
  • Non-elective/emergent and/or redo surgery.
  • Any preoperative hemodynamic support (mechanical or pharmaceutical).
  • Severe LV dysfunction (LVEF ≤ 30%).
  • Severe RV dysfunction.

研究组 & 干预措施

SUPERFICIAL PARASTERNAL INTERCOSTAL PLANE BLOCK (SPIPB)

Experimental

Following induction, ropivacaine 0.5% (1.5 mg/kg per each side) with dexamethasone 8mg/20ml is deposited under ultrasound guidance in the plane between the intercostal muscles and the pectoralis major muscles, targeting the anterior cutaneous branches of the intercostal nerves.

干预措施: Superficial Parasternal Block (SIPB) (Procedure)

SUPERFICIAL PARASTERNAL INTERCOSTAL PLANE BLOCK (SPIPB)

Experimental

Following induction, ropivacaine 0.5% (1.5 mg/kg per each side) with dexamethasone 8mg/20ml is deposited under ultrasound guidance in the plane between the intercostal muscles and the pectoralis major muscles, targeting the anterior cutaneous branches of the intercostal nerves.

干预措施: General anesthetic (Drug)

SUPERFICIAL PARASTERNAL INTERCOSTAL PLANE BLOCK (SPIPB)

Experimental

Following induction, ropivacaine 0.5% (1.5 mg/kg per each side) with dexamethasone 8mg/20ml is deposited under ultrasound guidance in the plane between the intercostal muscles and the pectoralis major muscles, targeting the anterior cutaneous branches of the intercostal nerves.

干预措施: Morphine (Drug)

ERECTOR SPINAE PLANE BLOCK (ESPB)

Active Comparator

Before induction, ropivacaine 0.5% (1.5 mg/kg per each side) with dexamethasone 8mg/20ml is deposited under ultrasound guidance between the transverse process of the 5th thoracic vertebra and the erector spinae muscle, targeting the dorsal and ventral rami of the spinal nerves.

干预措施: Erector Spinae Plane Block (ESPB) (Procedure)

ERECTOR SPINAE PLANE BLOCK (ESPB)

Active Comparator

Before induction, ropivacaine 0.5% (1.5 mg/kg per each side) with dexamethasone 8mg/20ml is deposited under ultrasound guidance between the transverse process of the 5th thoracic vertebra and the erector spinae muscle, targeting the dorsal and ventral rami of the spinal nerves.

干预措施: General anesthetic (Drug)

ERECTOR SPINAE PLANE BLOCK (ESPB)

Active Comparator

Before induction, ropivacaine 0.5% (1.5 mg/kg per each side) with dexamethasone 8mg/20ml is deposited under ultrasound guidance between the transverse process of the 5th thoracic vertebra and the erector spinae muscle, targeting the dorsal and ventral rami of the spinal nerves.

干预措施: Morphine (Drug)

结局指标

主要结局

Fentanyl consumption (µg/kg)

时间窗: during intraoperative period

Intraoperative opioid consumption after goal directed monitoring of nociception with the NOL index

Morphine consumption (µg/kg)

时间窗: 48 hours after surgery

Postoperative opioid consumption

次要结局

  • Extubated patients(2 hours after surgery)
  • Quality of postoperative analgesia(6 hours, 12 hours, 24 hours and 48 hours after extubation/ICU admission and 1 hour after drain removal)
  • Time to extubation(up to 24 hours after surgery)
  • Norepinephrine dose (mcg/kg)(intraoperative, 6 hours and 12 hours after surgery)
  • Time to weaning-off norepinephrine(up to 96 hours after surgery)
  • Dobutamine dose (mcg/kg)(intraoperative, 6 hours and 12 hours after surgery)
  • Time to first dose of morphine(any time for 48 hours)
  • Norepinephrine-free patients(2 hours after surgery)
  • Morphine-free patients(48 hours after surgery)

研究者

发起方
Institutul de Urgenţă pentru Boli Cardiovasculare Prof.Dr. C.C. Iliescu
申办方类型
Other
责任方
Principal Investigator
主要研究者

Balan Ion Cosmin

Principal Investigator

Institutul de Urgenţă pentru Boli Cardiovasculare Prof.Dr. C.C. Iliescu

研究点 (1)

Loading locations...

相似试验